IP Verse

Pharmaceutical Composition Capable Of The Incorporation Of Lenalidomide In Various Crystalline Modifications - EP3135275

PATENT ANALYSIS

Patent Details

Grant Date
May 13, 2020
Company
GRINDEKS, A JOINT STOCK COMPANY
Oppositions

BACHELIN, MARTIN

HOFFMANN EITLE PATENT- UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBB

SYNTHON BV

More patents of Grindeks, A Joint Stock Company

EP3135275

Want to monitor this patent?

Feel free to send us a message here and we will get back to you